Container Type: Universal Transport Medium (UTM), Viral Transport Medium (VTM)
Preferred Draw Volume
2 mL
Unacceptable Conditions
Frozen sample
Any sterile swab (ie BBL culturette) NOT placed in UTM/VTM
Storage/Transport Temperature
Refrigerate (2 - 8°C)
Stability (from collection to initiation)
Up to 4 hours at room temperature (approximately 23°C) or up to 3 days refrigerated (2-8° C)
Ordering Recommendations
The Respiratory Syncytial Virus (RSV) Antigen, Immunofluorescence test uses direct immunofluorescence to detect antigens of RSV in respiratory tract samples. The preferred tests to diagnose RSV infections is the RVP2 PCR or RSV-specific molecular tests, which detect RSV virus RNA by polymerase chain reaction (PCR). Rapid antigen tests can also be used; however, they are prone to produce false results during times of low disease prevalence.
Performed
Monday - Sunday
Methodology
Multiplexed Nucleic Acid test
Reported
1-2 days
Performing Lab
Virology
Synonyms
9963
Respiratory Pathogen Panel
Respiratory Viral Panel
Reference Interval
Not Detected
Clinical Interpretation
Multiplexed nucleic acid test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in NP swabs obtained from individuals suspected of respiratory tract infections. Organisms and subtypes identified include: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A (including subtypes H1, H1-2009 and H3), Influenza B, Parainfluenza Virus 1, 2, 3 and 4, Respiratory Syncytial Virus, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Results of this test should be used in conjunction with other clinical and epidemiological information and not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Negative results in the setting of a respiratory illness may be due to an infection with pathogens not detected by this test. Positive results do not rule out co-infection with other organisms.
CPT Codes
87633, 87581, 87486, 87798 (x2)
LOINC Codes
NAME
LOINC
Order
RVP2 PCR
50219-5
Result
Adenovirus PCR
39528-5
Bordetella parapertussis PCR
29723-4
Bordetella pertussis PCR
23826-1
Chlamydia pneumoniae PCR
34645-2
Coronavirus 229E PCR
41003-5
Coronavirus HKU1 PCR
62423-9
Coronavirus NL63
41005-0
Coronavirus OC43 PCR
41009-2
Human Metapneumovirus PCR
38917-1
Human Rhinovirus/Enterovirus PCR
40991-2
Influenza A 2009 H1 PCR
55465-9
Influenza A PCR
34487-9
Influenza A, H1 PCR
49521-8
Influenza A, H3 PCR
49524-2
Influenza B PCR
40982-1
Mycoplasma pneumoniae PCR
29257-3
Parainfluenza 1 PCR
29908-1
Parainfluenza 2 PCR
29909-9
Parainfluenza 3 PCR
29910-7
Parainfluenza 4 PCR
41010-0
RSV PCR
40988-8
Test Code (Outreach Synonym)
9963
Catalog Code
1659779734
Collection
Collect
Specimen Type: Nasopharyngeal swab
Container Type: Universal Transport Medium (UTM), Viral Transport Medium (VTM)
Preferred Draw Volume
2 mL
Unacceptable Conditions
Frozen sample
Any sterile swab (ie BBL culturette) NOT placed in UTM/VTM
Storage/Transport Temperature
Refrigerate (2 - 8°C)
Stability (from collection to initiation)
Up to 4 hours at room temperature (approximately 23°C) or up to 3 days refrigerated (2-8° C)
Ordering
Ordering Recommendations
The Respiratory Syncytial Virus (RSV) Antigen, Immunofluorescence test uses direct immunofluorescence to detect antigens of RSV in respiratory tract samples. The preferred tests to diagnose RSV infections is the RVP2 PCR or RSV-specific molecular tests, which detect RSV virus RNA by polymerase chain reaction (PCR). Rapid antigen tests can also be used; however, they are prone to produce false results during times of low disease prevalence.
Performed
Monday - Sunday
Methodology
Multiplexed Nucleic Acid test
Reported
1-2 days
Performing Lab
Virology
Synonyms
9963
Respiratory Pathogen Panel
Respiratory Viral Panel
Result Interpretation
Reference Interval
Not Detected
Clinical Interpretation
Multiplexed nucleic acid test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in NP swabs obtained from individuals suspected of respiratory tract infections. Organisms and subtypes identified include: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A (including subtypes H1, H1-2009 and H3), Influenza B, Parainfluenza Virus 1, 2, 3 and 4, Respiratory Syncytial Virus, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Results of this test should be used in conjunction with other clinical and epidemiological information and not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Negative results in the setting of a respiratory illness may be due to an infection with pathogens not detected by this test. Positive results do not rule out co-infection with other organisms.
